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Urine-reinfusion natriuresis: Evidence for potent natriuretic fac-
tors in rat urine, In awake rats the entire urine output was continu-
ously reinfused iv. Urine-reinfusion (UR) consistently led to the
appearance, within one to two hours, of massive, sustained natriu-
resis and diuresis, suggesting the existence of potent natriuretic
factors in the urine. At the time of maximal natriuresis, mean
sodium excretion rate and urine flow rate were 25 and 15 times
their respective values in control rats. This "urine-reinfusion na-
triuresis" could be demonstrated despite treatment with desoxy-
corticosterone acetate, blockage of prostaglandin synthesis by in-
domethacin or meclofenamate, reduction of plasma urea by
pretreatment with a protein-free diet, or heating the urine to
100°C. The natriuresis was not prevented by the absence of vaso-
pressin (in Brattleboro rats) and was augmented by vasopressin
infusion. In the Brattleboro rats, a marked increase in (CH,O +
C)/GFR with only a slight rise in C110/GFR during UR sug-
gests inhibition of both proximal and distal tubular reabsorption.
Renal blood flow and plasma flow increased markedly during UR
with a lesser rise in GFR, consistent with post-glomerular vasodi-
latation. Thus, the phenomenon of urine-reinfusion natriuresis
suggests the presence in rat urine of potent, heat-stable natriuretic
factors, whose action is largely independent of changes in miner-
alocorticoids, prostaglandins, urea, or vasopressin. Renal vasodi-
latation, with decreased sodium reabsorption at both proximal and
distal nephron sites, appears to play an important role in the
natriuresis.
Natriurèse au cours de Ia réinjection d'urine: Preuve de I'existence
de facteurs natriurétique et diurétique puissants dans I'urine de rat,
La totalité du debit urinaire a été réinjectée en continu chez des rats
éveillés. La réinfusion d'urine (UR) determine l'apparition, dans
un délai d'une a deux heures, d'une natriurèse et d'une diurèse
massive ce qui suggére Ia presence, dans l'urine, de facteurs natri-
urétiques puissants. Au moment de Ia natriurèse maximale les
debits de sodium et d'urine sont égaux a 25 et 15 fois leurs valeurs
respectives chez les animaux contrôles. Cette natriurèse par réinfu-
sion d'urine peut être obtenue malgré le traitment par l'acétate de
désoxycorticostérone, Ic blocage de Ia synthèse des prostaglandines
par l'indométhacine, Ia diminution de l'urée plasmatique au moyen
d'un pré-traitement consistant en une alimentation sans protéines
ou le chauffage de l'urine a 100° C. La natriurèse n'est pas empê-
chée par l'absence de vasopressine (rat Brattleboro), elle est aug-
mentée par l'administration de vasopressine. Chez Ic rat Brattle-
boro une augmentation importante de (CHo + C)/GFR avec
une augmentation non significative de CH2O/GFR au cours de
l'UR suggère l'inhibition de Ia reabsorption tubulaire proximale et
distale. Les debits sanguin et plasmatique rénaux augmentent de
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facon importante au cours de l'UR cependant que Ic debit de
filtration glomerulaire augmente moms, ce qui est compatible avec
une vasodilatation post glomérulaire. Ainsi Ic phénomène de Ia
natriurèse consecutive a Ia réinfusion d'urine suggère Ia presence,
dans I'urine, d'un facteur natriurétique puissant, thermostable
done l'action est pour une grande part indépendante des modifica-
tions des minéralocorticoTdes, des prostaglandines, de I'urée et de
Ia vasopressine. La vasodilatation rénale, qui diminue Ia réabsorp-
tion de sodium a Ia fois dans les regions proximale et distale du
néphron, semble jouer un role important dans Ia natriurèse.
In recent years, evidence from a number of labora-
tories has supported the existence of natriuretic fac-
tors in plasma or serum [1—3], urine [1, 4—6], and
renal tissue [7]. Such factors have been described
under conditions of chronic [1, 4, 6] and acute [3, 7]
volume expansion, and in chronic uremia [2, 5]. De-
spite intense investigational efforts, the anatomical
source, chemical nature, mechanism of action, and
stimulus for the appearance or "release" of these
factors have remained unsettled.
Recently, we reported evidence for a major role of
circulating natriuretic factors in the pathogenesis of
post-obstructive diuresis in rats [8]. In the course of
these experiments, we observed that continuous i.v.
reinfusion of the entire urine output in conscious rats
led to the appearance of massive natriuresis and diu-
resis [8, 9]. This phenomenon, which we have termed
"urine-reinfusion natriuresis" [10], has suggested the
presence of potent natriuretic factors in the urine.
The objective of the present study has been to
further characterize this remarkably intense natriu-
resis, and to examine its mechanisms. Our findings
support the concept of heat-stable natriuretic factors
in urine, and suggest that their action is largely unre-
lated to changes in minerálocorticoid, vasopressin, or
prostaglandin activity. Although urea may play a role
in the natriuresis, it appears that other natriuretic
factors are probably more important. Our data sug-
gest that both proximal and distal nephron sites may
be involved in the natriuresis, and that renal vasodila-
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tation may be a major natriuretic mechanism during
urine-reinfusion.
Methods
Experiments were performed in a total of 64 rats
weighing 175 to 345 g. All rats were Sprague-Dawley
males, except for three Long-Evans rats of the
Brattleboro strain [11]. The diet was commercial rat
chow (Ralston Purina Co., St. Louis, MO) and tap
water ad lib, except where otherwise noted. All ani-
mals, studied while awake and partially restrained,
were prepared as follows. On the morning of study,
during brief ether anesthesia, polyethylene PE-50
catheters were implanted in a femoral artery and
vein, and a PE-90 catheter was implanted in the
urinary bladder through a small midline suprapubic
incision. In six of the Sprague-Dawley rats, a catheter
was implanted in the left renal vein to permit sam-
pling of renal venous blood. In these animals, the left
renal vein was exposed via a midline abdominal in-
cisiori and punctured near the inferior vena cava with
a 27-gauge needle. A PE-lO catheter was inserted
through the needle hole and held in place with a drop
of adhesive (Eastman 910 Adhesive, Eastman Chem-
ical Products Inc., Kingsport, TN). All catheters were
brought externally, and the incisions were sutured.
After surgery each rat was placed in a restraining
cage, described previously [8], and food and drinking
water were subsequently withheld. The rats were al-
lowed to recover from anesthesia for approximately
90 mm before studies were performed. Renal func-
tion was examined by clearance techniques, using
carboxyl-'4C-inulin and glycyl-3H-para-aminohip-
puric acid (PAH). Arterial blood was sampled, and
arterial blood pressure was measured frequently
throughout the experiment via the arterial catheter.
In the six rats with renal venous catheters, left renal
venous blood was sampled simultaneously with arte-
rial blood. '4C-inulin and 3H-PAH concentration in
urine and plasma were measured by liquid scintilla-
tion techniques as previously described [12]. Plasma
and urine sodium and potassium concentrations were
determined by flame photometry, and plasma and
urine osmolality were measured with a vapor pres-
sure osmometer (Model 5100, Wescor, Inc., Logan,
UT). Plasma urea concentration was determined by
the phenate-hypochlorite method described by Faw-
cett and Scott [13]. A total of approximately 50il of
plasma or urine sufficed for all of these determina-
tions.
The following experimental protocols were carried
out:
Lirine-reinfusion (UR) in previously normal rats,
UR was performed in 34 previously normal rats,
using the servo-activated pump apparatus which we
have previously described [8]. Urine samples, ap-
proximately 0.1 ml, were collected periodically, and
simultaneous blood samples were obtained. The rats
received i.v. 5% dextrose in water throughout the
study at the rate of 5% of body wt per 24 hr in order
to replace insensible water loss [12]. Since excreted
inulin and PAH were reinfused, relatively stable
plasma concentrations of '4C-inulin and 3H-PAH re-
sulted from a single priming dose of these com-
pounds.
In the six rats with renal vein catheters, standard
clearance studies [12], consisting of three 20-mm col-
lection periods, were performed prior to beginning
UR. Left renal venous blood was sampled simultane-
ously with arterial blood.
Various protocols were followed in the remaining
28 UR rats without renal vein catheters. In five rats,
standard clearance studies (three 20-mm periods)
were performed prior to beginning UR. In four of
these five rats, clearance studies were performed after
UR had been abruptly discontinued. In nine rats, UR
was carried out for varying periods of time, and then
vasopressin (ADH) (Pitressin®, Parke-Davis and Co.,
Detroit, MI) (10 and/or 50 mU/kg of body wt per
hr) was infused i.v. while UR was continued. In eight
rats during UR, either indomethacin or meclofena-
mate was given i.v. in order to inhibit prostaglandin
synthesis: indomethacin, dissolved in a phosphate
buffer (pH, 8; 2 mg/mI), was given in a dose of 8
mg/kg of body wt, while meclofenamate, dissolved in
0.45% saline (5 mg/mI) was given as either one or two
doses of 20 mg/kg each. In three rats during UR,
urine was circulated through a 30-foot coil of silicone
rubber tubing (0.8 mm ID, 1.3 mm OD, initially filled
with 0.9% saline) immersed in a water bath at 100°C.
The calculated transit time through the heating coil
was 5 to 6 mm. The heated urine was cooled to room
temperature before reinfusion.
In addition to the above, the following rats were
subjected to UR:
Rats on a protein-free diet (UR-PF): Nine rats were
fed protein-free rat chow (ICN Nutritional Biochemi-
cals, Cleveland, OH), supplemented with 20% su-
crose and vitamins, for three to five days prior to
study in order to decrease endogenous urea produc-
tion. Five of the UR-PF rats were given desoxycorti-
costerone acetate (DOCA) in oil (1.0 mg, i.m.) the
evening before and the morning of surgery.
Chronically sodium-loaded rats (UR-Hi-Na).' Four
rats were given 1% NaCI to drink ad lib for 7 to 13
days prior to study.
Chronically sodium-depleted rats (UR-Lo-Na): Five
rats were fed sodium-free chow (ICN Nutritional
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Biochemicals, Cleveland, OH) and deionized drink-
ing water for 11 to 17 days prior to study.
Rats with diabetes insipidus (UR-DI): Three rats
with congenital diabetes insipidus (Brattleboro
strain) were given a gastric water lavage, 3% of body
wt, immediately prior to study. Standard clearance
studies were performed prior to beginning UR.
Sham-manipulated control rats (CONT): Standard
clearance studies were performed in nine rats which
did not undergo UR, At least three clearance periods
were done initially without ADH, and subsequently
with ADH i.v. at 10 and at 50 mU/kg of body wt per
hr. Data from the periods without ADH administra-
tion were compared with the control (pre-UR) data
of five of the UR rats without renal vein catheters,
and no significant differences were found. Therefore,
the results of these 14 rats were combined for com-
parisons with the other experimental models.
Calculations: In the six rats with left renal vein
catheters, total renal plasma flow (RPF) was calcu-
lated by the Fick principle, using Wolf's equation
[14]:
RPF = (UPAH - RV PAH) X V/(RAPAH — RVPAH)
where UPAH, RAPAH, and RVPAH are concentrations
of PAH in urine, arterial blood, and renal venous
blood, respectively, and V is urine flow rate. The
extraction ratio of PAH (EPAH) was calculated as:
EPAH = (RAPAH — RVPAH)/RAPAH
In these calculations, we assumed that the PAH con-
centrations of left and right renal venous blood were
equal. Renal blood flow (RBF) was calculated as
RPF/(l-Hct). Renal vascular resistance was calcu-
lated as the ratio of mean arterial blood pressure to
RBF. Statistics were calculated according to methods
described by Steel and Torrie [15]. Analysis of vari-
ance, with Duncan's multiple range test as modified
by Kramer, or Student's t test, were used as appro-
priate to compare group means. A probability value
(P) of less than 0.05 was regarded as significant.
Values are presented as the means 1 SEM.
Results
The effects of urine-reinfusion (UR): A total of 28
previously normal rats without renal vein catheters
were studied during UR. Five of these rats were
initially studied in the control state, then subjected to
UR. The clearance data and arterial blood pressures
(BP) of these five animals are depicted in Figure 1. A
marked increase in urine flow rate (V) and sodium
excretion rate (UNaV) occurred in all five rats within
50 to 70 mm after UR was begun. In one rat (denoted
by open triangles in Fig. 1), a 12-fold increase in V
and a 19-fold increase in UNaV were noted after 60
mm of UR. In this early phase of "urine-reinfusion
natriuresis," glomerular filtration rates (GFR) were
relatively stable in four rats, but decreased temporar-
ily in one animal. As UR was continued, Vtended to
plateau temporarily at 180 to 200 mm in four rats
(denoted by closed circles in Fig. 1) and then contin-
ued to rise progressively. In the remaining animal,
there was a sustained elevation in V as compared with
the other rats.
GFR remained relatively stable initially, but grad-
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Fig. 1. Time course of changes in urine flow rare (('), sodium excre-
tion rate (UNIt V), glomerular filtration rate (GFR), and mean arterial
blood pressure (BP) during urine-reinfusion (UR) in five previously
normal rats. Rates are expressed per kidney. Values at time zero
(vertical broken line) were observed during control clearance peri-
ods prior to UR. The data of one rat, whose course was distinctive
by the early onset of massive, sustained diuresis and natriuresis, are
indicated by open triangles. UR was abruptly discontinued in the
four other rats, as indicated by the open circles and broken lines.
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ually increased to levels that were significantly greater
than those noted in the control period (P < 0,05). BP
increased slightly in the early phase of UR in each
rat, and remained relatively stable thereafter. BP re-
corded at the time of maximal UNaV for each rat
averaged 12% greater than values observed during the
control period.
Most rats exhibited a fairly obvious maximal
plateau in urinary sodium and water excretion at
some point during UR, even though the magnitude of
diuresis and natriuresis observed and the time re-
quired to achieve this maximal response were quite
variable. Therefore, in order to compare the various
experimental groups, the data from the clearance pe-
riod in which maximal UNflV occurred were analyzed
as shown in Table 1. These results refer to UR with-
out the administration of ADH, indomethacin, or
nieclofenamate, or other experimental maneuvers.
These data are compared with the data from 14 con-
trol (CONT) rats, also without ADH being given.
Maximal UNaV occurred after 339 + 20 mm of UR
and was 25 times that of CONT rats. The largest
UNaV noted, 317 tEq/min/kg of body wt per kidney,
would be equivalent to approximately 30 times the
rat's total body sodium content per 24 hr. The frac-
tional excretion of the filtered sodium load (FENa)
exceeded 20% in seven of the UR rats. The animal
with the highest FENa, 30.2%, also had the largest
UNaV. Mean FENa in UR animals was increased to
16.5 + 1.2% compared with 0.93 0.9% for the
CONT rats. Urine flow rate at the time of maximal
UNaV was 15 times that of the CONT value, and in
eight of the UR rats equalled or exceeded
2000sl/min/kg per kidney. The highest value noted,
3730sl/min/kg per kidney, would be the equivalent
of 10 times the animal's body wt per 24 hr (total of
both kidneys). The fractional excretion of glomerular
filtrate (V/GFR) was 22.4 1.9% in the UR rats (vs.
2.0 + 0.2% for CONT rats, P <0.01), and attained
values greater than 37% in four animals. The rat with
the highest V and UNaV had a V/GFR of 47.5%.
Associated with this massive natriuresis and diu-
resis, mean GFR was increased by approximately
35% over the CONT rats. This increase in GFR was
not accompanied by a significant increase in PAH
clearance rate (CPAH). However, mean BP in UR
animals was significantly elevated to 132 2 mm Hg
compared with 121 2 mm Hg for CONT rats.
In addition to the marked natriuresis and diuresis
which occurred with UR, there was also a striking
kaliuresis. Potassium excretion rate (UKY) was in-
creased by over six-fold compared with CONT rats.
CK/GFR was increased from 27.2 + 3.0% in CONT
rats to 93.4 3.4% in UR rats, and exceeded 100% in
eight UR animals, indicating net tubular secretion of
potassium.
Table 2 gives measurements on arterial blood at
the time of maximal UNaV. As might be expected, the
mean plasma urea concentration (Pa) in the UR rats
was significantly elevated compared with the CONT
mean. Additionally, plasma potassium concentration
was significantly increased in the UR animals. There
were no significant changes in the plasma sodium
concentration, osmolality, or hematocrit of UR rats.
Renal hemodynamics before and during UR. Six pre-
viously normal rats with renal venous catheters were
studied before and during UR. Control (before UR)
values for V and UNaV in these rats were significantly
less (P < 0.001 for both) than those of the 14 CONT
rats (Table 1). These differences may have been an
Table 1. Clearance values (per kidney) and blood pressure at the time of maximal urinary sodium excretion''
Groupe,
no. of
rats
Duration of
urine-reinfusio
mm
'/
n jsl/,nin per kg
of body WI
GFR
mi/mm per kg
of body WI
CPAH
ml/mmnperkg
of body wi
U,V
/2Eq/min per
kg of body WI
FENa
%
UKV
zEq/mmn per
kg of WI
BP
mm
Hg
Control, 14 110 + 11 5.47 0.21 12.8 0.9 6.7 0.7 0.93 0.09 5.8 + 0.6 121 2
UR, 28 339 20 1633 + 124
(P <0.01)
7.48 0.24
(P <0.01)
14.9 0.9
NS
164 12
(P <0.01)
16.5 1.2
(P <0.01)
37.9 2.0
(P <0.01)
132 2
(P <0.01)
UR-PF, 9 34t + 25 1720 98
(P<0.01)
7.02 0.19
(P<0.05)
19.7 + 1.5
(P<0.0l)
126 10
(P<0.0l)
13.7 1.2
(P<0.0l)
10.4 + 1.9
NS
124 3
NS
UR-HI-Na, 4 366 44 1990 + 430
(P<0.01)
6.82 0.47
(P<0.05)
10.9 1.4
NS
196 + 53
(P<0.01)
20.6 4.3
(P<0.0l)
32.6 3.2
(P<0.0l)
131 5
NS
UR-Lo-Na, 5 477 + 23 1040 210
(P <0.01)
6.50 0.45
NS
13.9 1.5
NS
58 + 15
(P <0.05)
7.0 1.8
(P <0.05)
31.3 + 3.1
(P <0.01)
120 + 2
NS
UR-DI, 3 346±70 1380 + 60
(P < 0.01)
5.24 0.17
NS
12.2 3.3
NS
117 17
(P <0.01)
15.0 1.7
(P < 0.01)
15.5 4.9
(P < 0.05)
95 I
(P < 0.01)
a Values are means + ssM; P values refer to comparisons with Control group means; NS = not significant.
b '/ urine flow rate; GFR = glomerular filtration rate; CPAH para-aminohippurate clearance rate; UNaV = urinary sodium excretion
rate; FEN = fractional excretion of sodium; UKV = urinary potassium excretion rate; BP = mean arterial blood pressure.
UR urine-rcinfusion in previously normal rats; UR-PF = rats on a protein-free diet; UR-Hi-Na = chronically sodium-loaded rats:
UR-Lo-Na = chronically sodium-depleted rats; UR-DI = rats with diabetes insipidus.
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Table 2. Summary of measurements on arterial blood at the time of maximal urinary sodium excretions
Group,
Number of rats
[Na]
rnEq/liter
[K]
mEq/liter
Osmolality
mOsm/kg of H20
Hematocrit
%
[Urea]
mM
Control, 14 139 + 1 4.2 0.1 300 ÷ 3 41 0.4 4.5 0.4
UR,28 136+1
NS
5.7±0.2
(P<0.Ol)
306±2
NS
40±0.4
NS
21.8+ 1.9
(P<0.Ol)
UR-PF, 9 132 3
(P < 0.05)
4.3 0.2
NS
292 + 6
(P <0.05)
45 + 2.0
(P < 0.01)
6.2 + 0.9
NS
UR-Hi-Na,4 135 + 1
NS
5.3 + 0.4
(P <0.05)
309 5
NS
39 2.0
NS
18.9 + 1.5
(P <0.01)
UR-Lo-Na, 5 136 4
NS
6.0 0.3
(P<0.0l)
311 + 4
NS
44 0.5
(P<0.05)
18.4 1.1
(P<0.0I)
UR-DI, 3 147 + 1
(P <0.05)
4.3 + 0.1
NS
323 + 5
(P <0.01)
37 + 2.0
(P <0.05)
22.9 3.4
(P <0.01)
Values are means + SEM. P values refer to comparisons with Control group means. NS = not significant. See Table I for explanation
of abbreviations.
effect of the somewhat more extensive surgery re-
quired for the renal vein catheter implantation. Be-
cause of these differences, the data of these six rats
have been analyzed separately from the other groups,
and the results are shown in Table 3. The UR values
represent observations after 379 31 mm of UR, the
time of maximal UNaV. All six rats displayed intense
natriuretic and diuretic responses to UR, and the
values for and UNaV during UR are quite similar to
those of the other 28 UR rats (Table 1). GFR in-
creased significantly during UR, with a slight and
non-significant rise in CPAH. A striking degree of
renal vasodilatation was noted during UR, the renal
vascular resistance decreasing by 28%. Total renal
plasma flow (RPF) and renal blood flow (RBF) in-
creased markedly, associated with a substantial de-
crease in the renal extraction ratio of PAH (EPAH).
The increase in RPF was proportionately much
greater than that of GFR, with a resultant 28% de-
crease in whole-kidney filtration fraction (FF). BP in
this group increased by 8% (P > 0.2).
The effect of decreasing urea production. As noted
above, UR rats exhibited a significant elevation of P,
at the time of maximal UNaV. In order to examine the
role of urea, nine rats (UR-PF) were fed a protein-
free diet for five to nine days prior to UR. Mean P, in
the UR-PF rats at the time of maximal natriuresis
(Table 2) was not significantly different from that of
CONT rats, but was significantly lower than the P,, of
UR rats (P < 0.01).
Five of the UR-PF rats were treated with desoxy-
corticosterone acetate (DOCA) shortly before UR, in
order to insure a high level of mineralocorticoid ac-
tivity during the experiment. The results of these five
animals at the time of maximal UNaV did not differ
significantly from those of the four UR-PF rats that
did not receive DOCA, with regard to ", GFR,
UNaV, FENa, or duration of UR prior to maximal
UNaV (P> 0.2 in each case). Because of the absence
of a significant effect of DOCA, the data of all nine
UR-PF rats were combined (Table I).
Although Pu in the UR-PF rats did not differ from
P, in CONT rats, a marked natriuresis occurred.
Maximal UNaV—noted after 341 25 mm (a time
not significantly different from the UR rats)—was 19
times the CONT level, and approximately 75% of
that of UR animals (P < 0.05). The values of FEN
for UR-PF and UR rats did not differ significantly.
Mean in the UR-PF rats was nearly 16 times the
CONT mean, and slightly greater than the UR value.
GFR in the UR-PF rats was significantly increased,
to 128% of the CONT value, similar to the results
observed in UR animals.
Despite the comparable natriuresis, diuresis, and
increased GFR in the UR and UR-PF rats, these two
models differed from each other in several respects.
In contrast with the relatively unchanged CPAI.I in the
UR rats, CPAH in the UR-PF animals increased to
154% of the CONT mean (P < 0.01). Potassium
excretion in UR-PF rats was not significantly in-
creased over CONT values. The absence of a signifi-
cant kaliuresis despite the natriuresis, and the ab-
sence of a rise in plasma potassium concentration
(Table 2) may have been consequent to decreased
dietary potassium intake during treatment with pro-
tein-free chow. Plasma sodium concentration in
the UR-PF rats was decreased significantly compared
with the CONT rats, and plasma osmolality was sig-
nificantly less than that of either CONT or UR ani-
mals. In addition, the hematocrit of UR-PF rats was
significantly greater than those of either CONT or
UR rats, suggesting that the UR-PF animals may
have been relatively sodium depleted.' Finally, BP in
'The modified protein-free diet contained 42zEq/g of sodium and
l34sEq/g of potassium. These quantities are 23% and 56%, re-
spectively. of the amounts in commercial rat chow. Although we
did not measure dietary sodium and potassium intake in these
rats, it is likely that intakes were considerably below those of rats
on commercial chow.
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sodium excretion"
Before UR During UR P
;T'
p1/mm/kg of
bodvwl 35 +9 1576 <0.01
UNOV,
pEq,/min/kg of
bodywl 2.0 +0.5 169 20 <0.01
G FR,
nil/non/kg of
body WI 6.54 0.25 7.07 + 0.35 <0.05
CI,A,,
n1/niin/kg of
body wi 17.4 + 0.6 19.1 1.4 NS
EPAO, % 84.4 1.8 54.4 + 2.6 <0.01
RPF,
mi/mm/kg of
body wi 20.8 + 0.7 34.0 + 2.7 <0.01
RBF,
mi/mm/kg of
body WI 34.3 1.5 53.2 + 5.1 <0.01
BP,mmHg 110 +5 119 + 5 NS
RVR,
rPm? Jig. m1'
nmin' kg-'
of body WI 3.34 0.28 2.39 + 0.31 <0.01
FF(GFR/RPF),% 31.9 + 1.2 21.8 2.8 <0.01
"Values are means + I SEM. NS = not significant.
the UR-PF rats was not significantly different from
that of CONT animals.
The effect of chronic sodium—loading. Four rats
(UR-Hi-Na) drank 1% NaCI for 7 to 13 days prior to
UR, in order to produce a state of chronic sodium-
loading. This group exhibited the highest mean val-
ues for UNV and FENa of any of the models of this
study (Table I), although the degree of natriuresis
varied widely among the four animals. Comparison
of the UR-Hi-Na and the UR rats did not reveal any
significant differences with regard to clearance results
or BP (Table 1) or composition of arterial blood
(Table 2).
The effect of chronic sodium-depletion. In order to
examine the effect of sodium-depletion on the re-
sponse to urine-reinfusion, five rats (UR-Lo-Na)
were pretreated with a sodium-free diet for 11 to 17
days. Despite sodium-depletion, these rats displayed
a natriuresis and diuresis (UNaV and '1, both approxi-
mately nine times CONT values), as indicated in
Table 1. However, the natriuresis of the UR-Lo-Na
animals was markedly blunted and delayed in ap-
pearance in comparison with the UR rats. Maximal
UNaV was not observed until urine-reinfusion had
been carried out for 477 + 23 mm in the UR-Lo-Na
rats, approximately 30% longer than in the UR ani-
mals. Mean UNaV for the UR-Lo-Na rats was only
about one-third of that observed in the UR rats,
FENa was comparably reduced (P < 0.01 for both).
Also in contrast with the UR rats, GFR and BP were
not significantly different from CONT values. He-
matocrit in the UR-Lo-Na rats was significantly
greater than either the CONT or the UR-Hi-Na val-
ues, suggesting extracellular fluid (ECF) contraction
in these animals.
The effects of ADH on the phenomenon of urine-
reinfusion natriuresis were examined in two ways.
First, Brattleboro rats (UR-DI) with a complete ab-
sence of ADH were subjected to urine-reinfusion, As
shown in Table 1, these animals displayed a marked
natriuresis (UNaV approximately 17 times CONT)
and diuresis. Table 4 shows a comparison of clear-
ance results in the UR-DI rats before and during UR.
was increased nearly six-fold and UNaV approxi-
mately 26-fold (P < 0.01 for both). GFR rose 23%,
without a significant change in CPAH, comparable to
the results in Sprague-Dawley rats. However, in con-
trast with all the other models of this study, BP fell
significantly. The values of (C11 + CNa)/GFR, an
approximation of distal sodium delivery [161, in-
creased six-fold (P < 0.01). However, the increase in
solute-free water excretion (C/GFR) did not in-
crease significantly.
To further evaluate the importance of ADH,
Sprague-Dawley rats undergoing urine-reinfusion
natriuresis were given an i.v. infusion of ADH at two
different dose levels. The results of ADH administra-
Before UR During UR P
\;1,
p//olin/kgof
body mi'I
G FR,
in//nun/kg of
body wt
CPAl-h
mI/nnn/kg of
body wi
pEq/min/kgof
body WI
245
4.27 0.29
13.8 1.0
4.5 1,0
1380
5.24 0.17
12.2 + 3.3
117 + 17
<0.01
<0.05
NS
<0.01
FEND, %
(CH,o + CNa)/
GFR,%
0.7! 0.14
3.6 + 0.1
15.0 + 1.7
21.7 + 0.8
<0.01
<0.01
CH)/GFR,% 2.9 0.9 6.8 1.1 NS
BP, mom Hg Ill 3 95 + I < 0.05
+ SPM.
Table 3. Renal hemodynamic data (per kidney) in six rats before
and during urine-reinfusion (UR) at the time of maximal urinary
= extraction ratio of PAH; RPF = total renal plasma
flow; RBF = total renal blood flow; RVR = renal vascular
resistance; FF = filtration fraction. Other abbreviations are
explained in Table I.
Table 4. Clearance values (per kidney) and blood pressure in
three Brattleboro rats before and during urine-reinfusion (UR)
at the time of maximal urinary sodium excretion"'tm'
"Values are means NS not significant.
b (CH,,, + CNO)/GFR fractional distal sodium delivery;
CH,O/GFR = fractional excretion of solute-free water.
Other abbreviations are as shown in Table I.
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Fig. 2. The effects of infusing exogenous vasopressin (A DH) at either
10 or 50 mU/kg of body wt per hr in rats undergoing urine-reinfu-
sion. (*) indicates a significant difference (P < 0.05) compared with
the initial observations without ADH. (**) indicates a significant
difference compared with observations during ADH infusion, 50
mu/kg per hr.
tion are illustrated in Figure 2. At a dose of 10
mU/kg of body wt per hr, ADH infusion led to a 14%
fall in (P > 0.3), and a rise in the urine-to-plasma
osmolality ratio [(U/P)ogm] from 1,00 0.09 to 1.39
0.17 (P < 0.01). Despite this slight blunting of the
diuresis, UNaV increased by 39% (P < 0.01). This
increased natriuresis was associated with modest and
nonsignificant rises in both GFR and BP. Increasing
the ADH dose to 50 mU/kg per hr was followed by a
profound elevation of both S and UNaV to 160% and
235%, respectively, of the levels observed without
ADH administration. This massive natriuresis and
diuresis, the highest levels observed in this study,
were associated with a 35% rise in GFR and a 17%
increase in BP, both significant changes. Following
ADH administration at 50 mU/kg per hr, ADH was
discontinued. Compared with values observed in 50
mU/kg per hr, UNaV, GFR, and BP all fell signifi-
cantly after withdrawal of ADH, although UNaV re-
mained elevated above the initial level noted prior to
ADH administration. Interestingly, ' remained vir-
tually unchanged upon discontinuation of ADH,
while (U/P)osm decreased to 0.95 + 0.11.
Clearance studies were also performed in nine
sham-manipulated CONT rats without ADH, and
with ADH at 10 and 50 mU/kg per hr, the same
doses of ADH administered to UR rats. As shown in
Table 5, ' decreased with each dose of ADH to levels
significantly below the mean value without ADH ad-
ministration. In addition, GFR increased signifi-
cantly above the CONT value at each dose level. For
both and GFR, the differences between the levels at
10 and 50 mU/kg per hr were not significant. UNaV
and BP increased at both doses of ADH, but these
changes were not significant.
The effect of inhibiting prostaglandin synthesis. In
order to assess the possibility of a role for the prosta-
glandins in the phenomenon of urine-reinfusion natri-
uresis, eight rats were given either of two inhibitors
of prostaglandin synthesis, indomethacin or meclo-
fenamate, after varying durations of UR. As illus-
trated in Figure 3, the eight animals exhibited quite
variable changes in UNaV following administration of
the drugs. All but two of the animals showed a ten-
dency toward an increase in UNaV following adminis-
tration of the drugs; however, these changes were not
significant.
The effect of heating urine. In three rats, urine-
reinfusion was carried out for varying lengths of time,
after which the urine was heated to 100°C for 5 to 6
mm before reinfusion into the rat. As shown in Fig-
ure 4, this manipulation had essentially no effect on
UNaV. This result indicates that the urinary factors
responsible for urine-reinfusion natriuresis are stable
in the presence of this degree of heating.
The effects of discontinuing UR. Four rats under-
went UR for 360 to 410 mm, at which time UR was
abruptly discontinued. The ensuing large losses of
urinary electrolytes and fluid during this post-UR
ADH ' GFR UNV BP
mu/kg of i1/min per mi/mm per tEq/min per mm Hg
body wt kg of kg of kg of
perhr bodvwt bodywl bodywt
None 92.0 11.0 5.31 0.30 7.74 + 0.78 123 2
10 45.4 7.2
(P<0.0l)
6.47 + 0.22
(P<0.Ol)
10.72 1.57
NS
127 + 2
NS
50 32.5 + 1.9
(P<0.0l)
6.34 + 0.23
(P<0.0l)
8.85 0.56
NS
129 + 3
NS
Values are means + I SEM. P values refer to comparisons with
means during no ADH infusion. NS = not significant. Other
abbreviations are as shown in Table I.
ADH dosage 10
mU/perhr _________
o N0ADH
A ADH 10 mU/kg/hr
• ADH 50 mU/kg/hr
2000
1000
.0
300
0
200>0
100
150
100
0
4
Begin UR
Table 5. Renal function (per kidney) and blood pressure of nine
Control rats at varying doses of vasopressin (ADH)*
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period were not replaced. The results are shown in
Figure 1 by the broken lines and open circles. In each
of the four animals, both "I and UNaV dropped rap-
idly to initial control levels or below. Associated with
the cessation of natriuresis and diuresis, BP decreased
to levels comparable to those of the control periods.
GFR appeared to fluctuate markedly during this pe-
riod; however, due to the rapidly changing values of
plasma inulin concentration and urinary inulin excre-
tion rate observed, it is uncertain whether the calcu-
lated inulin clearance rates accurately reflected GFR,
Fluid loss in this post-UR period averaged 1.96
ml/l00 g of body wt, a volume equal to approxi-
mately 10% of ECF volume.
Discussion
In the present study, as in our earlier experiments
[8], the i.v. reinfusion of the entire urine output in
rats produced massive and sustained natriuresis and
diuresis. Since water and electrolyte balance
remained unchanged during UR, it is clear that urine-
reinfusion natriuresis is not due to salt or water over-
load. Rather, this phenomenon appears to be a con-
sequence of one or more potent natriuretic factors in
urine. The rapid appearance of the natriuresis in pre-
viously normal rats suggests that these factors are
constituents of normal urine. This represents a point
of difference from findings of other investigators,
who have detected natriuretic activity in urine in
response to sodium-loading [1, 3, 4, 6, 7] or the need
for increased sodium excretion in the uremic state [2,
5].
In an effort to delineate the mechanisms of urine-
reinfusion natriuresis, we directed attention in the
present study to the possible roles of various factors
that are recognized influences upon renal salt or wa-
ter excretion. These factors include renal hemody-
namics, urea, the mineralocorticoids, ADH, the pros-
taglandins, and dietary sodium intake.
The present data indicate that urine-reinfusion na-
triuresis is associated with marked changes in renal
hemodynamics. In the six rats with renal vein cath-
eters, in which total renal plasma flow (RPF) and
renal blood flow (RBF) were determined, a striking
degree of renal vasodilatation was observed. RPF
increased by 63% during UR, while GFR increased
by only 8%, with a resultant marked fall in filtration
fraction (Table 3). These results suggest that the
primary site of the vasodilatation was the efferent
(post-glomerular) vasculature. The mechanism of
this efferent vasodilatation is not identified by the
present data, but would appear to be mediated by one
or more urinary factors. Whether these factors are
themselves vasodilators, or whether they induce the
appearance of other substances that are vasodilators,
remains to be defined. Since, as Brenner et al have
shown, glomerular plasma flow is a major determi-
nant of GFR [17], the marked increase of RPF may
well account for the increase in GFR during urine-
reinfusion natriuresis.
The decrease in the renal extraction of PAH (EPAH)
observed during UR in the six rats with renal vein
catheters is not clearly explainable by our present
data. A fall in EPAU during renal vasodilatation has
been well-recognized previously [18—20], and has
been attributed both to intrarenal distribution of
blood flow [18] and to increased velocity of cortical
plasma flow, with reduction in time for trans-
membrane PAH diffusion to occur [20]. Addition-
ally, the depression of EPAH in the present experi-
ments could be a function of azotemia. It has been
>
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Fig. 3. The effects on sodium excretion rate (UN V, per kidney) of
administering indomethacin in 5 rats (closed circles) or meclofena-
mate in 3 rats (open circles) during urine-reinfusion. Broken lines
indicate the time of injecting drug.
>:
E
200/X/
100
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Fig. 4. The effect on sodium excretion rate (UN V. per kidney) of
heating urine to 1000 Cfor 5 to 6 mm prior to reinfusion in three rats.
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shown that PAH transport is inhibited by factors,
especially organic anions, present in serum in the
azotemic state [2 1—23]. In this regard, it is interesting
that CPAH in the present study increased significantly
during UR in only one group, the UR-PF rats. The
protein-free diet which these rats were fed might be
expected to have suppressed the accumulation of or-
ganic anions as well as urea. Thus, EPAH in the other
groups (on normal protein intake) may have been
depressed by the circulatory accumulation of organic
anions, as well, possibly, as by hemodynamic factors
related to renal vasodilatation.
Previous studies of circulating or urinary natriu-
retic factors have demonstrated [2, 5—7, 24] or im-
plied [1, 3, 4] an inhibition of tubular sodium reab-
sorption, rather than increased filtration, as the
mechanism or natriuresis. However, the present data
indicate that GFR was significantly increased at the
time of maximal UNaV in the UR, UR-PF and UR-
Hi-Na rats compared with CONT (Table 1), and in
the UR-DI rats compared with control values in the
same animals. In order to examine the role of hyper-
filtration versus decreased tubular reabsorption in
urine-reinfusion natriuresis, individual U NaY values
for UR and CONT rats are plotted as a function of
filtered sodium load in Figure 5. There was a consid-
erable degree of overlap in the filtered load values of
UR and CONT rats. In this range (less than 1000
zEq/min/kg of body wt) where filtered loads are
comparable, it is clear that the natriuresis in the UR
rats is due to decreased absolute sodium reabsorp-
tion. In the range of filtered load above
l000tEq/min/kg, it is not evident whether the so-
dium reabsorptive capacity of the kidney in the UR
rats has been further inhibited, or whether a maximal
transport rate for sodium has been exceeded, or both.
Regardless, these data indicate that a decrease in
tubular reabsorption and an increase in filtration may
both contribute to the natriuresis during UR. In ad-
dition, the present data suggest at least one ex-
planation for a decrease in tubular reabsorption.
Both in vivo [25, 26] and in vitro [27, 28] studies have
demonstrated a direct relationship between pen-
tubular oncotic pressure and tubular reabsorption
rate. Since, in the present study, filtration fraction
(FF) decreased from 32% to 22% (Table 3), it would
be expected that post-glomerular plasma protein con-
centration and peritubular oncotic pressure would be
decreased during urine-reinfusion natriuresis.2 Such a
decrease in peritubular oncotic pressure may have
contributed to an inhibition of tubular reabsorption
during UR, although other mechanisms of decreased
tubular reabsorption are possible as well.
Elevation of arterial BP may, in itself, inhibit tubu-
lar reabsorption [29, 301 and lead to a natriuresis [30,
31]. Even though increased BP was observed in the
UR rats (Table 1), our data do not suggest that BP is
a primary mediator of urine-reinfusion natriuresis. In
Figure 6, UNaV values of both UR and CONT rats
are plotted as a function of BP. For neither group is
the correlation between UNaV and BP significant. In
addition, it can be seen that, although considerable
overlap in BP values exists between JR and CONT
animals, UNaV values are widely separated. For the
ten UR rats with BP in the same range as observed
for most CONT rats (112 to 130 mm Hg), the mean
UNaV was 175 19zEq/min/kg of body wt, approxi-
mately 26 times the CONT value (P < 0.001). More-
over, BP was not significantly increased in any of the
other urine-reinfusion models (UR-PF, UR-Hi-Na,
UR-Lo-Na), and even fell significantly in the UR-DI
rats. Changes in BP, therefore, appear qualitatively
unimportant in the mechanism of urine-reinfusion
natriuresis.
Urea, which is regarded as an osmotic diuretic and
natriuretic [32], accumulates in the circulation of rats
undergoing UR (Table 2). Previously, we reported
that the i.v. infusion of urea into rats resulted in a
considerably less intense natriuresis and diuresis than
observed with UR, despite comparable elevations of
P [8]. In the present study, the role of urea in urine-
o 600 800 1000 1200
Filtered sodium load, p Eq/rn/n per kg of body wt
Fig. 5. The relationship between sodium excretion rate (UN,, V) and
filtered sodium load, for control rats and previously normal rats
during urine-reinfusion (UR). There is a significant correlation for
control rats(r = 0.694, P <0.01), but not for UR rats(r = 0.183, P
> 0.4).
A decrease in FF from 32% to 22% would be associated with a
13% fall in post-glomerular protein concentration, if one assumes
constant arterial protein concentration. Although we did not
measure plasma protein concentration, the lack of significant
change in arterial hematocrit between CONT and UR rats (Table
2) suggests that protein concentration remained relatively con-
stant.
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tion appears to exclude changes in mineralocorticoid
activity as a mediating factor in urine-reinfusion
natriuresis.
ADH, because of its multiple actions, might con-
ceivably play a complex role in urine-reinfusion natri-
uresis. Although long known for its antidiuretic
properties [33], ADH has more recently been recog-
nized as a natriuretic and diuretic agent in pharma-
cologic doses [34, 35]. In the present study, UR was
performed both in the complete absence of ADH (in
the UR-DI rats) and during i.v. infusion of ex-
ogenous ADH. The appearance of a marked
natriuresis in the UR-DI rats (Table 1) indicates that
ADH is not necessary for the phenomenon of urine-
reinfusion natriuresis. On the other hand, the in-
fusion of ADH in the UR rats produced a remark-
able enhancement of the natriuresis (Fig. 2), a phe-
nomenon not observed in the CONT rats (Table 5).
Since ADH is excreted in the urine [36], it is likely
that recirculation of excreted ADH resulted in much
higher blood levels of the hormone in UR rats than in
CONT rats receiving the same dose. The further ele-
vation of UNaV during ADH infusion in the UR rats
appears to be due to the additional natriuretic action
of ADH at high dose levels [35]. In the present ex-
periments, as in previous reports, the mechanism
whereby ADH exerts a natriuretic effect is unclear.
The exaggerated diuresis at the higher dose rate was
probably related to greatly increased delivery of
tubular fluid to the medullary collecting ducts, ex-
ceeding their ability to abstract solute-free water de-
spite maximal collecting duct water permeability.
100 120 140
Arterial blood pressure, mm Hg
Fig. 6. The relationship between sodium excretion rate (UN V. per
kidney) and mean arterial blood pressure for control rats and pre-
viously normal rats during urine-reinfusion (UR). There is no signifi-
cant correlation for either group: for control rats, r = 0.13, P >
0.5; for UR, r = 0.06, P > 0.8).
reinfusion natriuresis was further examined in the
protein-deprived UR-PF rats. The occurrence of a
marked natriuresis and diuresis in these rats, despite
a very modest rise in P and a depression of plasma
osmolality (Table 2), makes it unlikely that either urea
or other osmotically active solutes are the primary
mediators of the natriuresis. However, this result does
not exclude a role for urea as a natriuretic factor.
Figure 7 illustrates UNaV plotted as a function of P
for CONT, UR, and U R-PF rats. The majority of P
values for the UR-PF animals overlap with the
CONT values, although UNaV values for the UR-PF
rats are consistently much greater. No significant cor-
relation exists between P and UNV for either UR-
PF or CONT rats. However, in the UR rats, a posi-
tive correlation does occur (r = 0.628, P < 0.001). It
is possible that, in the UR model, the plasma accu-
mulation of urea, while contributing little natriuretic
activity itself, may serve as a "marker" for the accu-
mulation of other unidentified natriuretic factors. Al-
ternatively, urea might exert a natriuretic action that
is additive to that of other natriuretic factors during
UR. The occurrence of natriuresis and diuresis fol-
lowing urea infusion [8] makes the latter hypothesis
appear more likely.
The possibility that mineralocorticoid secretion
might decline during UR, thereby contributing to an
increase in sodium excretion, was evaluated by treat-
ing UR-PF rats with pharmacologic doses of the
mineralocorticoid DOCA. The failure of DOCA ad-
ministration to significantly alter V or UNV in com-
parison with UR-PF rats without DOCA administra-
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Fig. 7. The relationship between plasma urea concentration and
sodium excretion rate (UN, V), per kidney) in sham-manipulated
control rats, previously normal rats during urine-reinfusion (UR),
and protein-deprived rats during urine-reinfusion (UR-PF). The re-
pression line is given for the UR rats.
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Such a phenomenon has been well-described :fl rats
undergoing marked osmotic diuresis [37]. These re-
suits indicate that, while endogenous ADH is un-
likely to contribute to urine-reinfusion natritiresis,
pharmacologic levels of ADH are capable of pro-
foundly intensifying the phenomenon.
The prostaglandin compounds have been shown to
have natriuretic and renal-vasodilator properties [38,
39]. The possibility of the prostaglandins playing a
mediating role in urine-reinfusion natriuresis was
evaluated by administering indomethacin or meclo-
fenamate to UR rats. Renal prostaglandirl syn-
thesis has been shown to be markedly inhibited by
indomethacin indogs [40, 41]and rats [42], and by
meclofenamate in dogs [40] and rabbits [43] at doses
less than those used in the present study. The failure
of either indomethacin or meclofenamate to signifi-
cantly alter the natriuresis in the present experiments
(Fig. 3) suggests that the prostaglandins are not re-
sponsible for the marked natriuretic response to UR.
The possible relationship between the urine-reinfu-
sion natriuresis demonstrated in the present study
and the mechanisms responsible for regulating salt
and water homeostasis is of obvious interest. In the
UR-Hi-Na rats, prior sodium-loading produced a
modest and nonsignificant enhancement of urine-
reinfusion natriuresis. In contrast, the natriuresis was
markedly attenuated by chronic sodium-deprivation
(UR-Lo-Na rats). Such a result appears to parallel
the observation of Schmidt, Bourgoignie, and Bricker
[44] that a humoral natriuretic factor demonstrable
in uremic dogs on normal sodium intake is not de-
tectable when sodium intake is restricted. Taken to-
gether, these data suggest that sodium-deprivation in
rats might inhibit the production of the urinary fac-
tors that mediate urine-reinfusion natriuresis, a con-
cept consistent with a role for these factors in the
regulation of sodium balance. However, it appears
equally plausible that ECF volume contraction, sec-
ondary to the sodium-deprivation, may non-specifi-
cally blunt the responsiveness of the kidney to the
natriuretic stimuli of urine-reinfusion. Such an anti-
natriuretic effect of ECF contraction may well ex-
plain the rapid cessation of natriuresis that follows
the interruption of UR (Fig. 1). Pending further in-
formation, it does not seem justified to draw any firm
conclusion regarding the role of the urinary factors
responsible for urine-reinfusion natriuresis in the
regulation of sodium balance.
Except for the inhibition of proximal tubular reab-
sorption by the uremic serum fraction reported by
Weber, Bourgoignie, and Bricker [24], little data exist
regarding the site of action of previously reported
natriuretic factors. In the present study, the UR-DI
rats exhibited a marked rise in fractional distal so-
dium delivery, as reflected by (CH2O + CNa)/GFR,
during natriuresis. This finding, as well as the marked
elevations of FENa and '/GFR in a number of UR
rats, is compatible with inhibition of proximal frac-
tional reabsorption. Additionally, it is possible that
the distal nephron is involved in urine-reinfusion
natriuresis. Although CH2O/GFR rose during natri-
uresis in each of the UR-DI rats, the increase is not
significant. In each animal, the increase in C20/GFR
is proportionately much less than the increase in
(C2o + CNa)G FR.3 The relative depression of free-
water formation is consistent with an additional inhi-
bition of sodium chloride transport in the diluting
segment of the nephron.
In summary, the present data support the follow-
ing conclusions: a) potent, heat-stable natriuretic fac-
tors appear to be components of normal rat urine; b)
the natriuretic activity of these factors is probably
mediated, to an important degree, by post-glomeru-
lar renal vasodilatation; c) the mechanism of natriu-
resis is essentially independent of changes in ADH,
mineralocorticoids, or prostaglandin; d) although
urea may exert a natriuretic action during urine-rein-
fusion, it appears likely that other natriuretic factors
are of much greater importance; and e) both prox-
imal and distal nephron sites may contribute to the
natriuresis. The anatomic source, chemical composi-
tion, and number of the urinary natriuretic factors
involved in urine-reinfusion natriuresis are not estab-
lished by our present data. Additionally, it remains to
be determined whether the urinary factors, when
reinfused, act directly upon the kidney, or whether
their actions are indirect.
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(CH + CN3)/GFR have been shown to increase proportionately
during hypotonic saline loading, as (CN3o + CN)/GFR is in-
creased into ranges comparable to values noted in our UR-DI
rats [45}.
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